Evidence map›Paper›PMID 32400356›Full record

Trial reportThe American journal of tropical medicine and hygiene2020

Impact of Different Mass Drug Administration Strategies for Gaining and Sustaining Control of

Charles H King, Nupur Kittur, Sue Binder, Carl H Campbell, Eliézer K N'Goran, Aboulaye Meite, Jürg Utzinger, Annette Olsen, Pascal Magnussen, Safari Kinung'hi and 13 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 57 citations in OpenAlex.

  1. SCORE Studies on the Impact of Drug Treatment on Morbidity due toThe American journal of tropical medicine and hygiene · 2020
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Effectiveness of Four Different Interventions Against Schistosoma haematobium in a Seasonal Transmission Setting of Côte d'Ivoire: A Cluster Randomized Trial.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Trial
  7. Trial
  8. Trial
  9. SCORE Operational Research on Moving toward Interruption of Schistosomiasis Transmission.The American journal of tropical medicine and hygiene · 2020
    Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Development of prediction models to identify hotspots of schistosomiasis in endemic regions to guide mass drug administration.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 13 institutions in 9 countries.

Charles H King1Center for Global Health and Diseases, Case Western Reserve University, Cleveland, Ohio.
Nupur Kittur2Schistosomiasis Consortium for Operational Research and Evaluation, Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Sue Binder2Schistosomiasis Consortium for Operational Research and Evaluation, Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Carl H Campbell2Schistosomiasis Consortium for Operational Research and Evaluation, Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Eliézer K N'Goran3Unité de Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, Abidjan, Côte d'Ivoire.
Aboulaye Meite5Programme National de Lutte Contre les Maladies Tropicales Négligées à Chimiothérapie Préventive (PNLMTN-CP), Abidjan, Côte d'Ivoire.
Jürg Utzinger6Swiss Tropical and Public Health Institute, Basel, Switzerland.
Annette Olsen8Section for Parasitology and Aquatic Pathobiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Pascal Magnussen9Centre for Medical Parasitology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Safari Kinung'hi10National Institute for Medical Research, Mwanza, Tanzania.
Alan Fenwick11Schistosomiasis Control Initiative, Imperial College, London, United Kingdom.
Anna E Phillips11Schistosomiasis Control Initiative, Imperial College, London, United Kingdom.
Pedro H Gazzinelli-Guimaraes11Schistosomiasis Control Initiative, Imperial College, London, United Kingdom.
Neerav Dhanani11Schistosomiasis Control Initiative, Imperial College, London, United Kingdom.
Josefo Ferro12Catholic University of Mozambique, Beira, Mozambique.
Diana M S Karanja13Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Pauline N M Mwinzi13Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
Susan P Montgomery14Centers for Disease Control and Prevention, Atlanta, Georgia.
Ryan E Wiegand6Swiss Tropical and Public Health Institute, Basel, Switzerland.
William Evan Secor14Centers for Disease Control and Prevention, Atlanta, Georgia.
Amina A Hamidou15Réseau International Schistosomoses, Environnement, Aménagement et Lutte (RISEAL-Niger), Niamey, Niger.
Amadou Garba16Department of Control of Neglected Tropical Diseases, Preventive Chemotherapy and Transmission Control Unit, World Health Organization, Geneva, Switzerland.
Daniel G Colley2Schistosomiasis Consortium for Operational Research and Evaluation, Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, Georgia.
Imperial College London · GBUniversity of Georgia · USCenters for Disease Control and Prevention · USKenya Medical Research Institute · KEUniversity of Copenhagen · DKCatholic University of Mozambique · MZCenter for Global Health · USCentre de Recherche Médicale et Sanitaire · NENational Institute for Medical Research · TZSwiss Tropical and Public Health Institute · CHUniversité Félix Houphouët-Boigny · CIUniversity of Basel · CHWorld Health Organization · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report summarizes the design and outcomes of randomized controlled operational research trials performed by the Bill & Melinda Gates Foundation-funded Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) from 2009 to 2019. Their goal was to define the effectiveness and test the limitations of current WHO-recommended schistosomiasis control protocols by performing large-scale pragmatic trials to compare the impact of different schedules and coverage regimens of praziquantel mass drug administration (MDA). Although there were limitations to study designs and performance, analysis of their primary outcomes confirmed that all tested regimens of praziquantel MDA significantly reduced local

Indexed as

Mass Drug AdministrationSchistosomiasis haematobiaSchistosomiasis mansoniAfricaAnimalsAnthelminticsChildDrug Administration ScheduleFemaleHumansMalePraziquantelPrevalenceSchistosoma haematobiumSchistosoma mansoniSnailsAnthelminticsPraziquantelWater

Identifiers

PMID32400356
PMCPMC7351298
OpenAlexW3025276086

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.